Clinical Trials in Belfast, Antrim

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

NCT ID: NCT04300556

This clinical trial is testing a new treatment called farletuzumab ecteribulin for patients with certain types of solid tumors, such as ovarian cancer, endometrial cancer, non-small cell lung cance...